• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN MFG SOLUTIONS S.A. PERITONEAL CATHETER; CATHETER, PERITONEAL, LONG-TERM INDWELLING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN MFG SOLUTIONS S.A. PERITONEAL CATHETER; CATHETER, PERITONEAL, LONG-TERM INDWELLING Back to Search Results
Model Number PERITONEAL CATHETER
Device Problems Break (1069); Obstruction of Flow (2423); Infusion or Flow Problem (2964)
Patient Problem No Information (3190)
Event Date 12/20/2015
Event Type  malfunction  
Manufacturer Narrative
Title: 'tenckhoff tunneled peritoneal catheter placement in the palliative treatment of malignant ascites: technical results and overall clinical outcome.Source: radiology and oncology,' 2016; 50(2): 197-203.If information is provided in the future, a supplemental report will be issued.
 
Event Description
According to the literature, source of study performed in 94 patients (27 men; 28.7% and 67 women; 71.3%) between march 2006 and january 2013 that analyzed the technical feasibility and safety of the insertion of a peritoneal tunnelled catheter.The overall clinical outcomes in this patient population were analysed and the authors evaluated the feasibility and safety of intraperitoneal chemotherapy delivery through the catheter in patients with widespread ovarian cancer and refractory ascites using catumaxomab.All patients were successfully inserted with tunneled peritoneal catheter; in 90 patients, catheter was tunneled subcutaneously into the right flank, in the remaining 4 patients the peritoneal access was made in the left para and infraumbilical region and the catheter was tunneled in the left flank.Minor complications were noted like ascitic fluid leakage around the entry point of the catheter in the right flank (n = 4; 4%), catheter occlusion (n = 2; 2%) and sleeve formation around the tip of the catheter resulting in insufficient drainage (n = 1; 1%).Management of these complications included extra skin sutures around the catheter entry point (n = 4), catheter removal (n = 1) or catheter flushing (n = 2).The use of this device to administer chemotherapy is not an approved indication and as such is considered off label use.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERITONEAL CATHETER
Type of Device
CATHETER, PERITONEAL, LONG-TERM INDWELLING
Manufacturer (Section D)
COVIDIEN MFG SOLUTIONS S.A.
edificio b20, calle #2
alajuela 20101
CR  20101
Manufacturer (Section G)
COVIDIEN MFG SOLUTIONS S.A.
edificio b20, calle #2
alajuela 20101
CR   20101
Manufacturer Contact
lisa hernandez
15 hampshire street
mansfield, MA 02048
2034925563
MDR Report Key10808589
MDR Text Key215299646
Report Number3009211636-2020-00277
Device Sequence Number1
Product Code FJS
Combination Product (y/n)N
Reporter Country CodeBE
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 11/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/09/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberPERITONEAL CATHETER
Device Catalogue NumberPERITONEAL CATHETER
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/26/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age60 YR
-
-